Oral health challenges in pediatric oncology patients

INTRODUCTION

Pediatric oncology patients face unique challenges during their treatment journey, particularly in maintaining oral health. The oral cavity is highly susceptible to the side effects of cancer therapies such as chemotherapy, radiation, and immunosuppressive treatments. These therapies, while essential for treating malignancies, can significantly compromise the integrity of the oral mucosa, salivary glands, and overall oral environment, leading to a range of complications such as mucositis, infections, and xerostomia.¹ The impact of these oral health challenges extends beyond physical discomfort, as they can severely affect a child's ability to eat, speak, and maintain nutritional intake, thereby influencing their overall quality of life and treatment outcomes.²

The relationship between oncology treatments and oral health is multifaceted. Chemotherapy, for example, targets rapidly dividing cells, which include not only cancer cells but also the cells of the oral mucosa. This can result in mucositis, a painful inflammation and ulceration of the mucous membranes, which is one of the most common oral complications in pediatric cancer patients.³ Radiation therapy, particularly when directed at the head and neck region, can exacerbate these issues by causing long-term damage to the salivary glands, leading to dry mouth and increased susceptibility to infections and dental caries.⁴ The immunosuppression caused by these treatments also makes pediatric oncology patients more prone to oral infections, such as candidiasis and herpes simplex virus reactivation, which can further complicate their clinical management.

Given the critical role oral health plays in the overall well-being of pediatric oncology patients, it is essential to implement preventive and therapeutic strategies tailored to this vulnerable population. Regular dental assessments before, during, and after cancer treatment can help mitigate the risk of severe oral complications. Moreover, a multidisciplinary approach that includes pediatric oncologists, dentists, and nutritionists is vital to provide comprehensive care that addresses both the medical and oral health needs of these patients.² This review aims to explore the oral health challenges faced by pediatric oncology patients, discuss the impact of cancer therapies on the oral cavity, and highlight the importance of interdisciplinary care in managing these complications.

REVIEW

The discussion of oral health challenges in pediatric oncology patients centers around the complex interplay between cancer therapies and oral complications. Chemotherapy and radiation therapy, both common treatments in pediatric oncology, significantly impact the oral cavity. Chemotherapy, due to its systemic nature, affects rapidly dividing cells, including the oral mucosa, leading to mucositis and increased susceptibility to infections.⁵ Mucositis is particularly debilitating, causing pain, difficulty in eating, and increased risk of systemic infections due to the breakdown of the mucosal barrier. This condition not only affects the child’s nutritional intake but also prolongs hospital stays and may necessitate treatment delays, which can impact overall cancer outcomes.

Radiation therapy, especially when involving the head and neck, adds another layer of complexity to oral health management. Long-term effects such as xerostomia and osteoradionecrosis are prevalent and challenging to manage. Xerostomia, or dry mouth, results from the damage to salivary glands, leading to a reduction in saliva flow, which is crucial for oral hygiene and the prevention of dental caries and infections.⁶ The lack of saliva also affects the child’s ability to speak and swallow, further impacting their quality of life. Comprehensive and multidisciplinary oral care is essential to prevent and manage these complications effectively.

IMPACT OF CHEMOTHERAPY AND RADIATION ON ORAL HEALTH

Chemotherapy and radiation therapy are pivotal in the treatment of pediatric cancers, but their impact on oral health can be profound and multifaceted. Chemotherapy, which targets rapidly dividing cells, affects not only malignant cells but also normal tissues such as the oral mucosa. This can lead to mucositis, a common and painful condition characterized by inflammation and ulceration of the mucous membranes. Mucositis can significantly impair a child’s ability to eat, speak, and maintain oral hygiene, and it often requires analgesic and supportive care to manage.⁷ The incidence and severity of mucositis can vary depending on the type and dosage of chemotherapy, but it remains a critical concern for pediatric oncology patients.

Radiation therapy, especially when directed at the head and neck region, introduces additional oral health challenges. One of the most significant long-term effects of radiation therapy is xerostomia, or dry mouth, resulting from damage to the salivary glands. Xerostomia decreases saliva production, which is essential for maintaining oral health by aiding in digestion, preventing dental caries, and controlling oral microbial populations.⁶ The reduction in saliva flow increases the risk of dental caries, periodontal disease, and oral infections, and it can also affect the child’s ability to speak, swallow, and taste, thereby reducing their quality of life. In addition to xerostomia, radiation therapy can lead to osteoradionecrosis, a severe condition in which the irradiated bone becomes necrotic and fails to heal properly. Osteoradionecrosis is particularly challenging to manage, as it can cause significant pain, dysfunction, and even disfigurement. The risk of osteoradionecrosis increases with higher doses of radiation and can be exacerbated by trauma or dental extractions within the irradiated area.⁸ Therefore, preventive dental care before radiation therapy is crucial to minimize the risk of this debilitating condition.

The combined effects of chemotherapy and radiation on the oral cavity necessitate a multidisciplinary approach to care. Pediatric oncologists, dentists, and other healthcare providers must work together to implement preventive strategies, such as regular dental check-ups, fluoride treatments, and good oral hygiene practices, to mitigate these risks. Additionally, early intervention in managing complications like mucositis and xerostomia can help improve the overall quality of life for pediatric oncology patients. Addressing these oral health challenges not only reduces discomfort but also supports better treatment outcomes and long-term oral health.

PREVENTION AND MANAGEMENT OF ORAL COMPLICATIONS IN PEDIATRIC ONCOLOGY

The prevention and management of oral complications in pediatric oncology patients are critical aspects of comprehensive cancer care. These complications, including mucositis, xerostomia, and infections, can significantly impact a child's quality of life and may even necessitate interruptions in cancer treatment. Preventive strategies are essential in minimizing the onset of these complications, and effective management protocols are required to address them when they occur.

One of the most important preventive measures is the implementation of a thorough oral care regimen before the initiation of cancer therapy. This involves pre-treatment dental evaluations to identify and address any existing oral health issues, such as caries or periodontal disease, that could be exacerbated by chemotherapy or radiation therapy. Regular oral hygiene practices, including brushing with a soft-bristled toothbrush, flossing, and the use of non-alcoholic mouthwashes, can help reduce the risk of mucositis and other complications.⁹ Additionally, fluoride treatments and dental sealants may be used to protect the teeth from the increased risk of decay associated with xerostomia.

For managing mucositis, various approaches have been explored. Cryotherapy, or the application of ice chips to the mouth during chemotherapy, has been shown to reduce the incidence and severity of mucositis in some patients by reducing blood flow to the oral mucosa and limiting the exposure of cells to chemotherapy agents.¹⁰ Furthermore, low-level laser therapy (LLLT) has gained attention as a non-invasive treatment option for mucositis. LLLT has been demonstrated to reduce pain, promote healing, and decrease the duration of mucositis, making it a valuable tool in the management of this complication in pediatric oncology patients.^11,12

Managing xerostomia requires a combination of preventive and therapeutic strategies. Saliva substitutes and stimulants, such as pilocarpine, can help alleviate dry mouth symptoms. Additionally, patients should be encouraged to stay hydrated and use sugar-free gum or lozenges to stimulate saliva production. The use of humidifiers during sleep can also help maintain moisture in the oral cavity. In cases where xerostomia leads to secondary complications like dental caries or oral infections, prompt dental interventions are necessary to prevent further deterioration of oral health.¹²

INTERDISCIPLINARY APPROACHES TO ORAL CARE IN PEDIATRIC CANCER PATIENTS

The management of oral health in pediatric cancer patients requires an interdisciplinary approach that integrates the expertise of oncologists, dentists, nurses, dietitians, and other healthcare professionals. This collaborative model ensures comprehensive care, addressing both the medical and dental needs of the child throughout their cancer treatment journey. The complexity of oral complications arising from chemotherapy and radiation therapy necessitates coordinated efforts to prevent, identify, and manage these issues effectively.

One key component of this interdisciplinary approach is the early involvement of dental professionals in the cancer care team. Dentists play a crucial role in pre-treatment evaluations, identifying existing oral health problems that could be exacerbated by oncology treatments.¹² This early intervention allows for the implementation of preventive strategies, such as dental cleanings, fluoride treatments, and the extraction of non-restorable teeth, to reduce the risk of complications during cancer therapy. Regular dental check-ups throughout treatment help monitor the patient’s oral health and address any emerging issues promptly. Nurses also play a vital role in the interdisciplinary care of pediatric oncology patients, particularly in the day-to-day management of oral hygiene and monitoring for signs of complications such as mucositis and infections. They provide education to both patients and their families on the importance of maintaining oral hygiene during treatment and offer practical guidance on managing symptoms. Nurses are often the first to notice changes in a patient's oral health, making their role critical in early detection and intervention.¹³

Dietitians contribute to the interdisciplinary team by addressing the nutritional challenges that arise due to oral complications. For example, mucositis and xerostomia can make eating difficult, leading to nutritional deficiencies that may impair the child’s ability to tolerate cancer treatments. Dietitians work with the patient and family to develop a nutrition plan that accommodates these challenges, such as recommending softer foods, nutritional supplements, and adequate hydration to support overall health.¹⁴ Their input is essential in ensuring that the child's nutritional needs are met despite the oral complications associated with cancer therapy. Overall, the interdisciplinary approach to oral care in pediatric cancer patients is essential for optimizing outcomes and improving quality of life. By involving multiple healthcare professionals, this model of care ensures that the various aspects of oral health are addressed in a coordinated and comprehensive manner, ultimately supporting the child's overall well-being during their cancer treatment.

CONCLUSION

Managing oral health challenges in pediatric oncology patients requires a comprehensive and multidisciplinary approach. Early preventive measures, effective management of complications, and collaboration among healthcare professionals are essential to mitigate the adverse effects of cancer treatments on the oral cavity. By prioritizing oral health, we can enhance the overall quality of life and treatment outcomes for pediatric cancer patients. Continuous efforts to refine and implement these strategies will further improve patient care in this vulnerable population.

Funding: No funding sources

Conflict of interest: None declared

Ethical approval: Not required

REFERENCES

1. 1. Sonis ST. Oral mucositis in cancer therapy. J Support Oncol. 2004;2(6-3):3-8.
2. 2. Cheng KK-F, Leung S, Liang RH, Tai JW, Yeung RM, Thompson DR. Severe oral mucositis associated with cancer therapy: impact on oral functional status and quality of life. Support Care Cancer. 2010;18(11):1477-85.
3. 3. Supportive P, Board PCE. Oral Complications of Chemotherapy and Head/Neck Radiation (PDQ®). In: PDQ Cancer Information Summaries. National Cancer Institute (US). 2022.
4. 4. Hancock PJ, Epstein JB, Sadler GB. Oral and dental management related to radiation therapy for head and neck cancer. J Can Dent Assoc. 2003;69(9):585-90.
5. 5. Cheng KKF, Lee V, Li CH, Yuen HL, Epstein JB. Oral mucositis in pediatric and adolescent patients undergoing chemotherapy: the impact of symptoms on quality of life. Support Care Cancer. 2012;20(10):2335-42.
6. 6. Jensen S, Pedersen A, Vissink A, Andersen E, Brown CG, Davies AN, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer. 2010;18(8):1039-60.
7. 7. Elting LS, Cooksley CD, Chambers MS, Garden AS. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys. 2007;68(4):1110-20.
8. 8. Vahidi N, Lee TS, Daggumati S, Shokri T, Wang W, Ducic Y. Osteoradionecrosis of the midface and mandible: pathogenesis and management. Semin Plast Surg. 2020;34(4):232-44.
9. 9. Cheng KK, Goggins WB, Lee VW, Thompson DR. Risk factors for oral mucositis in children undergoing chemotherapy: a matched case-control study. Oral Oncol. 2008;44(11):1019-25.
10. 10. Peterson D, Bensadoun R-J, Roila F. Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann Oncol. 2011;22(6):vi78-84.
11. 11. Blakaj A, Bonomi M, Gamez ME, Blakaj DM. Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data. Oral Oncol. 2019;95:29-34.
12. 12. Hong CH, Hu S, Haverman T, Monique S, Joel JN, Den Braber JB, et al. A systematic review of dental disease management in cancer patients. Support Care Cancer. 2018;26(1):155-74.
13. 13. Cawley MM, Benson LM. Current trends in managing oral mucositis. Clin J Oncol Nurs. 2005;9(5):584-92.
14. 14. Lalla RV, Bowen JM. Mucositis (oral and gastrointestinal). The MASCC textbook of cancer supportive care and survivorship. 2018;409-20.